Results 31 to 40 of about 34,596 (267)

Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report

BMC Medical Genetics, 2017
Background Familial Mediterranean fever is an autosomal recessive disease characterized by recurrent episodes of fever and polyserositis and by the onset of reactive amyloid-associated amyloidosis. Amyloidosis due to familial Mediterranean fever can lead
Ramón Peces, Sara Afonso, Carlos Peces, Julián Nevado, Rafael Selgas   +4 more
doaj   +1 more source

A patient with familial Mediterranean fever mimicking diarrhea-dominant irritable bowel syndrome who successfully responded to treatment with colchicine: a case report

Journal of Medical Case Reports, 2022
Background Irritable bowel syndrome is a functional gastrointestinal disease. Visceral hypersensitivity is the most important pathophysiology in irritable bowel syndrome. Currently, diagnosis of irritable bowel syndrome is based on symptoms and exclusion
Shima Kumei, Masatomo Ishioh, Yuki Murakami, Katsuyoshi Ando, Tsukasa Nozu, Toshikatsu Okumura   +5 more
doaj   +1 more source

International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor–Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome [PDF]

, 2016
Objective: Periodic fever syndrome (PFS) conditions are characterized by recurrent attacks of fever and localized inflammation. This study examined the diagnostic pathway and treatments at tertiary centers for familial Mediterranean fever (FMF), tumor ...
Cantarini, L, Cimaz, R, Degun, R, Foeldvari, I, Frenkel, J, Gul, A, Hentgen, V, Kone-Paut, I, Kuemmerle-Deschner, JB, Lachmann, HJ, Livneh, A, Lomax, KG, Marinsek, N, Ozen, S, Patel, D, Quartier, P, Savic, S, Spalding, S, Weiss, J, Zeft, A   +19 more
core   +2 more sources

The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature

Journal of Inflammation Research, 2020
Familial Mediterranean Fever (FMF) is the most prevalent genetic autoinflammatory disorder. In most patients, treatment with colchicine can prevent attacks of fever and inflammation.
M. Kačar, S. Savic, J. V. D. van der Hilst   +2 more
semanticscholar   +1 more source

Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells [PDF]

, 1996
Contains fulltext : 4837.pdf (publisher's version ) (Open ...
Drenth, J.P.H., Kushner, I., Meer, J.W.M. van der   +2 more
core   +9 more sources

Familial Mediterranean Fever and COVID-19: Friends or Foes?

Frontiers in Immunology, 2020
Familial Mediterranean Fever (FMF) and COVID-19 show a remarkable overlap of clinical symptoms and similar laboratory findings. Both are characterized by fever, abdominal/chest pain, elevation of C-reactive protein, and leukocytosis.
A. Stella, M. Lamkanfi, P. Portincasa
semanticscholar   +1 more source

A novel single variant in the MEFV gene causing Mediterranean fever and Behçet’s disease: a case report

Journal of Medical Case Reports, 2018
Background Familial Mediterranean fever is an autoinflammatory disease of unknown etiology, characterized clinically by recurrent attacks of sudden-onset fever with arthralgia and/or thoracoabdominal pain and pathogenetically by autosomal recessive ...
Maria Zerkaoui, Fatima Zahra Laarabi, Yousra Ajhoun, Bouchra Chkirate, Abdelaziz Sefiani   +4 more
doaj   +1 more source

Clinical and functional characterisation of a novel TNFRSF1A c.605T > A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. [PDF]

, 2008
Objectives: To study the clinical outcome, treatment response, T-cell subsets and functional consequences of a novel tumour necrosis factor (TNF) receptor type 1 (TNFRSF1A) mutation affecting the receptor cleavage site.
B H Belohradsky, C Dejaco, C Duftner, K Huss, M Herold, M Schirmer, P Lohse, S Stojanov   +7 more
core   +1 more source

EULAR recommendations for the management of familial Mediterranean fever

Annals of the Rheumatic Diseases, 2016
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease, but many rheumatologists are not well acquainted with its management.
S. Ozen, E. Demirkaya, B. Erer, A. Livneh, E. Ben-Chetrit, G. Giancane, H. Ozdogan, Illana Abu, M. Gattorno, P. Hawkins, Sezin Yuce, T. Kallinich, Y. Bilginer, D. Kastner, L. Carmona   +14 more
semanticscholar   +1 more source

Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF)

Genes, 2020
The gastrointestinal tract hosts the natural reservoir of microbiota since birth. The microbiota includes various bacteria that establish a progressively mutual relationship with the host.
A. Di Ciaula, A. Stella, L. Bonfrate, D. Q. Wang, P. Portincasa   +4 more
semanticscholar   +1 more source